WallStreetZenWallStreetZen

NASDAQ: NOTV
Inotiv Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NOTV

Based on 1 analyst offering 12 month price targets for Inotiv Inc

Min Forecast
$5.00+275.94%
Avg Forecast
$5.00+275.94%
Max Forecast
$5.00+275.94%

Should I buy or sell NOTV stock?

Based on 1 analyst offering ratings for Inotiv Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NOTV's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NOTV as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NOTV stock forecasts and price targets.

NOTV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-08

1 of 1

Forecast return on equity

Is NOTV forecast to generate an efficient return?

Company
N/A
Industry
11.03%
Market
143.01%

Forecast return on assets

Is NOTV forecast to generate an efficient return on assets?

Company
N/A
Industry
14.71%

NOTV earnings per share forecast

What is NOTV's earnings per share in the next 1 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.84

NOTV revenue forecast

What is NOTV's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$545.1M+13.48%
Avg 2 year Forecast
$793.1M+65.09%
Avg 3 year Forecast
$868.5M+80.78%
NOTV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NOTV revenue growth forecast

How is NOTV forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
23.24%
Industry
5.48%
Market
24.88%
NOTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NOTV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NOTV vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NOTV$1.33$5.00+275.94%Strong Buy
VNRX$0.43$3.50+713.95%Strong Buy
BDSX$6.83$32.50+375.84%Strong Buy
PRPO$20.50N/AN/A
DRIO$13.99$60.00+328.88%Strong Buy
View Top Diagnostic & Research Stocks

Inotiv Stock Forecast FAQ

Is Inotiv Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NOTV) stock is to Strong Buy NOTV stock.

Out of 1 analyst, 1 (100%) are recommending NOTV as a Strong Buy, 0 (0%) are recommending NOTV as a Buy, 0 (0%) are recommending NOTV as a Hold, 0 (0%) are recommending NOTV as a Sell, and 0 (0%) are recommending NOTV as a Strong Sell.

If you're new to stock investing, here's how to buy Inotiv stock.

What is NOTV's earnings growth forecast for 2026-2026?

(NASDAQ: NOTV) Inotiv's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 16.1%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.

Inotiv's earnings in 2025 is -$87,474,000.

In 2026, NOTV is forecast to generate -$63,072,068 in earnings, with the lowest earnings forecast at -$61,608,631 and the highest earnings forecast at -$63,845,010.

What is NOTV's revenue growth forecast for 2026-2028?

(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of 23.24% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.88%.

Inotiv's revenue in 2025 is $480,402,000.On average, 5 Wall Street analysts forecast NOTV's revenue for 2026 to be $18,727,182,427, with the lowest NOTV revenue forecast at $17,990,998,108, and the highest NOTV revenue forecast at $19,279,578,313. On average, 3 Wall Street analysts forecast NOTV's revenue for 2027 to be $27,245,690,382, with the lowest NOTV revenue forecast at $26,177,312,766, and the highest NOTV revenue forecast at $28,047,145,358.

In 2028, NOTV is forecast to generate $29,834,187,274 in revenue, with the lowest revenue forecast at $28,664,124,843 and the highest revenue forecast at $30,711,562,332.

What is NOTV's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: NOTV) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 14.71%.

What is NOTV's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NOTV price target, the average NOTV price target is $5.00, with the highest NOTV stock price forecast at $5.00 and the lowest NOTV stock price forecast at $5.00.

The Wall Street analyst predicted that Inotiv's share price could reach $5.00 by May 8, 2026. The average Inotiv stock price prediction forecasts a potential upside of 275.94% from the current NOTV share price of $1.33.

What is NOTV's Earnings Per Share (EPS) forecast for 2026-2026?

(NASDAQ: NOTV) Inotiv's current Earnings Per Share (EPS) is -$3.19. In 2026, NOTV's EPS is forecast to hit -$1.84 (min: -$1.79, max: -$1.86).

What is NOTV's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: NOTV) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.